InvestorsHub Logo

Cognition

01/19/14 7:05 PM

#674 RE: stockjuicer #673

Thanks for sharing. My favorite part was:
The technology also has minimal competition in the marketplace in terms of comparable advancements to traditional catheter manipulation methods. Further, the company has an already defensible and widening moat in the form of patents and regulatory clearances that are expensive to obtain. This moat should help Stereotaxis maintain high gross margins on its products for several years.

Bright future for STXS.